ENTAEnanta Pharmaceuticals, Inc.
$12.10+9.2% 1Y
$12.10
$10.4752 weeks$16.85
Is the price fair?
Watch
1 to watch, 2 without dataAt the top of its own P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Vs its own P/E rangedearer than 92% of its own historyderived
Expensive vs its own history: P/E 45.9 vs a 27.4 median over 13 quarters (+68% vs median).
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.